MiNK TherapeuticsINKT
那斯達克 · USD
12.18
-0.24
(-1.93%)
收盤 12/16 04:11 (UTC+8)
12/16 04:11 (UTC+8)
MiNK TherapeuticsINKT
12.18
-0.24
(-1.93%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | |
營業收入淨額 | - | - | - | - | - | - | - | - | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | - | - | - | - | - | - |
營業費用 | 3,183 | 4,052 | 2,701 | - | - | - | 3,829 | 5,500 | 5,223 | 6,343 |
研發費用 | 1,143 | 1,839 | 1,262 | 1,406 | 541 | 1,840 | 2,549 | 3,311 | 3,427 | 4,558 |
推銷及管理費用 | 2,040 | 2,213 | 1,439 | 1,097 | 1,344 | 1,231 | 1,280 | 2,189 | 1,796 | 1,785 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -3,184 | -4,052 | -2,701 | -2,503 | -1,885 | -3,071 | -3,830 | -5,500 | -5,224 | -6,343 |
其他收入及費用 | 296 | -185 | -66 | 40 | 78 | 369 | 17 | 42 | 107 | 146 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -2,888 | -4,238 | -2,767 | -2,463 | -1,807 | -2,702 | -3,813 | -5,459 | -5,116 | -6,197 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -2,888 | -4,238 | -2,767 | -2,463 | -1,807 | -2,702 | -3,813 | -5,459 | -5,116 | -6,197 |
基本每股稅後盈餘(元) | -0.65 | -1.06 | -0.70 | - | -0.05 | -0.07 | -0.11 | - | -0.15 | -0.18 |
稀釋每股稅後盈餘(元) | -0.63 | -1.06 | -0.70 | -0.06 | -0.04 | -0.07 | -0.11 | -0.15 | -0.15 | -0.18 |
基本平均股數(千股) | 4443.00 | 3981.00 | 3964.00 | - | 39533.00 | 37142.00 | 34642.00 | - | 34497.00 | 34409.00 |
稀釋平均股數(千股) | 4443.00 | 3981.00 | 3964.00 | - | 39533.00 | 37142.00 | 34642.00 | - | 34497.00 | 34409.00 |
還原基本每股稅後盈餘(元) | -0.65 | -1.06 | -0.70 | - | -0.46 | -0.73 | -1.10 | - | -1.50 | -1.80 |
還原稀釋每股稅後盈餘(元) | -0.63 | -1.06 | -0.70 | -0.62 | -0.42 | -0.72 | -1.10 | -1.54 | -1.50 | -1.80 |
還原基本平均股數(千股) | 4,443 | 3,981 | 3,964 | - | 3,953 | 3,714 | 3,464 | - | 3,449 | 3,440 |
還原稀釋平均股數(千股) | 4,443 | 3,981 | 3,964 | - | 3,953 | 3,714 | 3,464 | - | 3,449 | 3,440 |
EBITDA(千元) | -2,844 | -4,189 | -2,716 | -2,409 | -1,744 | -2,657 | -3,759 | -5,405 | -5,063 | -6,145 |